These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7195210)

  • 1. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
    Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
    Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
    Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
    Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of AR-L 115 BS with isoprenaline on hemodynamic parameters in the isolated guinea pig heart.
    Schrader J
    Arzneimittelforschung; 1981; 31(1a):183-5. PubMed ID: 7195216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
    Nebel W; Sabin G; Surawitzki G
    Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
    Wollschläger H; Drexler H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
    Stauch M; Nechwatal W
    Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF; Bubenheimer P; Roskamm H
    Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic activity of different doses of sulmazole by infusion.
    Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
    Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
    Weikl A; Kohlschütter S; Durst OE; Lang E
    Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiments with AR-L 115 BS on skinned cardiac fibers.
    Trube G; Trautwein W
    Arzneimittelforschung; 1981; 31(1a):185-8. PubMed ID: 7195217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
    Pozenel H
    Arzneimittelforschung; 1981; 31(1a):263-6. PubMed ID: 7195238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
    Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G
    Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New cardiotonic/inodilator agents: energetic aspects].
    Hasenfuss G
    Z Kardiol; 1992; 81 Suppl 4():57-63. PubMed ID: 1290307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium transport in sarcoplasmic reticulum in the presence of AR-L 115 BS].
    Hasselbach W
    Arzneimittelforschung; 1981; 31(1a):191-3. PubMed ID: 7195219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
    von Meel JC
    Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.